Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 AUD | -1.49% | -8.33% | +60.98% |
05-01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
04-22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+60.98% | 120M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Approval for Pediatric Kidney Disease Plan in Europe